Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Aug 19, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Meta-Analysis of Human Cancer Single-Cell RNA-Seq Datasets Using the IMMUcan Database.

Jordi Camps¹, Floriane Noël², Robin Liechti³

¹Biomedical Data Science, Research & Early Development Oncology, Bayer AG, Berlin, Germany.

Cancer Research

|December 2, 2022

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Cancer immunology research·2026

Same author

Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients.

Cancer research·2025

Same author

Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients.

Cancer research·2025

Same author

Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC.

Future oncology (London, England)·2025

Same author

Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment.

Nature communications·2024

Same journal

Inhibiting PPM1D Perturbs Mitochondrial Integrity to Stimulate cGAS-STING Signaling and Antitumor Immunity.

Cancer research·2026

Same journal

BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial Sarcoma.

Cancer research·2026

Same journal

Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer.

Cancer research·2026

Same journal

Opportunities to enhance cancer research through advocate-researcher partnerships.

Cancer research·2026

Same journal

EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.

Cancer research·2026

Same journal

Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

Cancer research·2026

See all related articles

This summary is machine-generated.

Researchers have developed IMMUcan scDB, a user-friendly database for human cancer single-cell RNA sequencing data. This resource aids in analyzing the tumor microenvironment and discovering new insights into cancer biology.

Area of Science:

Oncology
Bioinformatics
Immunology

Background:

Single-cell RNA sequencing (scRNA-seq) is crucial for understanding the tumor microenvironment (TME).
Numerous scRNA-seq studies offer valuable data but face challenges due to heterogeneity and processing complexities.
Exploiting this vast data requires integrated and accessible resources.

Approach:

Developed IMMUcan scDB, a dedicated database for human cancer scRNA-seq data.
Integrated 144 datasets across 56 cancer types with detailed annotations.
Implemented a four-step pipeline: data collection, processing, supervised cell annotation, and analysis interface.

Key Points:

IMMUcan scDB provides a user-friendly platform for non-specialists.
Features include 50 annotation fields covering clinical, technological, and biological information.

More Related Videos

Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq

Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq

Published on: March 12, 2021

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

Related Experiment Videos

Last Updated: Aug 19, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq

Multiplexed Analysis of Retinal Gene Expression and Chromatin Accessibility Using scRNA-Seq and scATAC-Seq

Published on: March 12, 2021

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

Enables gene-centric and cell-centric analyses, and meta-analyses of immune cells and genes in cancer.

Conclusions:

IMMUcan scDB is a freely accessible resource for human cancer scRNA-seq data analysis.
Facilitates exploration of the tumor microenvironment across various cancer types.
Offers extensive possibilities for downstream discovery and validation studies in cancer research.